(Q45862681)

17 December 2017

title

Gene therapy for ocular neovascularization: a cure in sight (English)

1 reference

17 December 2017

1 reference

Samuel J Reich

1

1 reference

17 December 2017

Jean Bennett

series ordinal

2

1 reference

17 December 2017

publication date

1 June 2003

1 reference

17 December 2017

Current Opinion in Genetics & Development

published in

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

317-322

1 reference

17 December 2017

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Diabetic macular edema: review and update

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Gene therapy and retinitis pigmentosa: advances and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Pharmacologically regulated gene expression in the retina following transduction with viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Immune responses limit adenovirally mediated gene expression in the adult mouse eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Vascular endothelial growth factor gene regulation and action in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Nucleic-acid therapeutics: basic principles and recent applications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Liver-directed gene transfer vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Identification of an Inhibitor of Neovascularization from Cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Inhibition of angiogenesis by tissue inhibitor of metalloproteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Systemically expressed soluble Tie2 inhibits intraocular neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

Gene therapy for ocular angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2803%2900043-1

7 January 2021

10.1016/S0959-437X(03)00043-1

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

12787796

1 reference

17 December 2017